Skip to content
★ Sign in to follow
PG

Paul Giannasca

Executive
Genocea Biosciences, Inc.
Total declarations
16
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (8 ops.)
€214k

Latest filing published 15 Sept 2014 for Genocea Biosciences, INC., €6,363.

Insider track record

Disclosed buys
0
Disclosed sells
8
Signal history

No signal scores available.

Paul Giannasca: trading record in brief

Paul Giannasca discloses dealings in Genocea Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 27 August 2014 to 11 September 2014, the count stands at 16 filings.

On the market, this insider has only sold: 8 sales, €214k in total. Besides market trades, the filings include 8 option exercises.

On 15 September 2014 came the latest disclosure, an option exercise for €6,363 in Genocea Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Paul Giannasca

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations